Investigational antiarrhythmic agents: promising drugs in early clinical development

Jordi Heijman; Shokoufeh Ghezelbash; Dobromir Dobrev

doi:10.1080/13543784.2017.1353601

Investigational antiarrhythmic agents: promising drugs in early clinical development

Jordi Heijman, Shokoufeh Ghezelbash, Dobromir Dobrev^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	897-907
Number of pages	11
Journal	Expert Opinion on Investigational Drugs
Volume	26
Issue number	8
DOIs	https://doi.org/10.1080/13543784.2017.1353601
Publication status	Published - 2017

Keywords

Antiarrhythmic drugs
atrial fibrillation
calcium handling
ion channels
sudden cardiac death
POLYMORPHIC VENTRICULAR-TACHYCARDIA
LATE SODIUM CURRENT
CHRONIC ATRIAL-FIBRILLATION
SMALL-CONDUCTANCE CALCIUM
SUDDEN CARDIAC DEATH
QUESTIONING FLECAINIDES MECHANISM
ACTIVATED POTASSIUM CHANNELS
RECEPTOR POTENTIAL CHANNELS
INTACT PORCINE MODEL
HEART-FAILURE

Access to Document

10.1080/13543784.2017.1353601

Cite this

Heijman, J., Ghezelbash, S., & Dobrev, D. (2017). Investigational antiarrhythmic agents: promising drugs in early clinical development. Expert Opinion on Investigational Drugs, 26(8), 897-907. https://doi.org/10.1080/13543784.2017.1353601

@article{d025708f12aa4573a1a4f41d53cfd88f,

title = "Investigational antiarrhythmic agents: promising drugs in early clinical development",

keywords = "Antiarrhythmic drugs, atrial fibrillation, calcium handling, ion channels, sudden cardiac death, POLYMORPHIC VENTRICULAR-TACHYCARDIA, LATE SODIUM CURRENT, CHRONIC ATRIAL-FIBRILLATION, SMALL-CONDUCTANCE CALCIUM, SUDDEN CARDIAC DEATH, QUESTIONING FLECAINIDES MECHANISM, ACTIVATED POTASSIUM CHANNELS, RECEPTOR POTENTIAL CHANNELS, INTACT PORCINE MODEL, HEART-FAILURE",

author = "Jordi Heijman and Shokoufeh Ghezelbash and Dobromir Dobrev",

year = "2017",

doi = "10.1080/13543784.2017.1353601",

language = "English",

volume = "26",

pages = "897--907",

journal = "Expert Opinion on Investigational Drugs",

issn = "1354-3784",

publisher = "Routledge/Taylor & Francis Group",

number = "8",

}

TY - JOUR

T1 - Investigational antiarrhythmic agents

T2 - promising drugs in early clinical development

AU - Heijman, Jordi

AU - Ghezelbash, Shokoufeh

AU - Dobrev, Dobromir

PY - 2017

Y1 - 2017

KW - Antiarrhythmic drugs

KW - atrial fibrillation

KW - calcium handling

KW - ion channels

KW - sudden cardiac death

KW - POLYMORPHIC VENTRICULAR-TACHYCARDIA

KW - LATE SODIUM CURRENT

KW - CHRONIC ATRIAL-FIBRILLATION

KW - SMALL-CONDUCTANCE CALCIUM

KW - SUDDEN CARDIAC DEATH

KW - QUESTIONING FLECAINIDES MECHANISM

KW - ACTIVATED POTASSIUM CHANNELS

KW - RECEPTOR POTENTIAL CHANNELS

KW - INTACT PORCINE MODEL

KW - HEART-FAILURE

U2 - 10.1080/13543784.2017.1353601

DO - 10.1080/13543784.2017.1353601

M3 - Review article

VL - 26

SP - 897

EP - 907

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 8

ER -